Optimizing designs in clinical trials with an application in treatment of Epidermolysis bullosa simplex, a rare genetic skin disease

Joakim Nyberg(Uppsala University), Verena Wally(Paracelsus Medical University), Martin Laimer(Paracelsus Medical University), Geert Molenberghs(University of Antwerp), Andrew C. Hooker(Uppsala University), Johan Verbeeck(Hasselt University), Georg Zimmermann(University of Salzburg), Konstantin Emil Thiel(Paracelsus Medical University), Martin Geroldinger(Paracelsus Medical University)
Computational Statistics & Data Analysis
July 2, 2024
10.1016/j.csda.2024.108015
Cited by 1

Related Papers

Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
|The Lancet|2022|408
High prevalence of foot diseases in Europe: results of the Achilles Project
|Mycoses|2003|194
Prognostic relevance of serum lactate kinetics in critically ill patients
|Intensive Care Medicine|2018|166
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
|Pharmaceutics|2022|92